Remote clinical trials are especially important in light of the COVID-19 pandemic, and the U.S. Food & Drug Administration has issued guidance for clinical trials during this time. On March…
Read More
In early March, Koneksa’s Chief Scientific Officer, Elena Izmailova, Ph.D., presented at the pre-conference workshop “Digital Medicine 101” and shared the results of Koneksa work at the “Digital Tools Enabling…
As part of Koneksa’s participation in the recent Immuno-Oncology Conference (IO360), CEO Chris Benko summarized Koneksa’s work in oncology. In the often technical world of oncology research, the human patients…
Recently, Koneksa’s CEO Chris Benko and I had the opportunity to participate – and I had the opportunity to present – at a workshop on “Remote Digital Monitoring for Medical…
Koneksa is the leader in developing and implementing patient-focused digital biomarkers for drug development. Koneksa’s value is in our ability to innovate with our clients and find the best fit…
The tree is out at the curb, the menorah is packed away, the new calendars are hanging on the wall: It’s time to take a breath in the new year,…
